Last Updated: November 13, 2026

Novast Labs Company Profile

« Back to Dashboard

What is the competitive landscape for NOVAST LABS

NOVAST LABS has forty-eight approved drugs.

There are six tentative approvals on NOVAST LABS drugs.

Summary for Novast Labs

US Patents:	0
Tradenames:	44
Ingredients:	27
NDAs:	48

Drugs and US Patents for Novast Labs

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Novast Labs Ltd	WERA	ethinyl estradiol; norethindrone	TABLET;ORAL-28	091204-001	Mar 27, 2012	AB	RX	No	Yes		⤷ Start Trial				⤷ Start Trial
Novast Labs	PRAMIPEXOLE DIHYDROCHLORIDE	pramipexole dihydrochloride	TABLET, EXTENDED RELEASE;ORAL	213444-006	Feb 3, 2022	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Novast Labs	YAELA	drospirenone; ethinyl estradiol	TABLET;ORAL-28	202015-001	Nov 19, 2014	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Novast Labs	OXYBUTYNIN CHLORIDE	oxybutynin chloride	TABLET;ORAL	210611-001	Oct 30, 2019	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Novast Labs	SETLAKIN	ethinyl estradiol; levonorgestrel	TABLET;ORAL	090716-001	Sep 15, 2014	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.